Pure Global

Rapamycin Target Eluting Coronary Stent System - India CDSCO Medical Device Registration

Rapamycin Target Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000366_3fba776a36a187f3455d08ebc1c9c9c2_d296c3c8e7fcb1f85445e18344006c50. This device is marketed under the brand name Firehawk Liberty. The license holder is MicroPort Scientific India Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Rapamycin Target Eluting Coronary Stent System
UID: IMP/MD/2018/000366_3fba776a36a187f3455d08ebc1c9c9c2_d296c3c8e7fcb1f85445e18344006c50

Brand Name

Firehawk Liberty

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Firehawk LibertyTM Rapamycin Target Eluting Coronary Stent System (Firehawk Liberty) is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions length โ‰ค 60 mm with reference vessel diameters of โ‰ฅ 2.25 to โ‰ค 4.0 mm

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing